Best Practices for Aggregate Quantitation of Antibody Therapeutics by Sedimentation Velocity Analytical Ultracentrifugation

J Pharm Sci. 2022 Jul;111(7):2121-2133. doi: 10.1016/j.xphs.2021.12.023. Epub 2022 Jan 2.

Abstract

Analytical ultracentrifugation (AUC) is a critical analytical tool supporting the development and manufacture of protein therapeutics. AUC is routinely used as an assay orthogonal to size exclusion chromatography for aggregate quantitation. This article distills the experimental and analysis procedures used by the authors for sedimentation velocity AUC into a series of best-practices considerations. The goal of this distillation is to help harmonize aggregate quantitation approaches across the biopharmaceutical industry. We review key considerations for sample and instrument suitability, experimental design, and data analysis best practices and conversely, highlight potential pitfalls to accurate aggregate analysis. Our goal is to provide experienced users benchmarks against which they can standardize their analyses and to provide guidance for new AUC analysts that will aid them to become proficient in this fundamental technique.

Keywords: Analytical ultracentrifugation; Antibody drug(s); Antibody(s); Biopharmaceutical characterization; HPLC (high performance/pressure liquid chromatography; Monoclonal antibody(s); Protein aggregation.

Publication types

  • Review
  • Research Support, N.I.H., Intramural

MeSH terms

  • Antibodies, Monoclonal* / chemistry
  • Chromatography, Gel
  • Ultracentrifugation / methods

Substances

  • Antibodies, Monoclonal